Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Urinary Markers Show Promise in ASD
Screening and monitoring Analytical science Biochemistry and molecular biology Research and Innovations

Urinary Markers Show Promise in ASD

Findings add to growing evidence in favor of microbiome-associated metabolite analysis for ASD screening and stratification

06/15/2026 News 3 min read
  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Top Institutions
  • Topic Commentary

Share

3 Topic Commentaries

Urinary Markers Show Promise in ASD

Urinary Markers Show Promise in ASD

  • Christina K. Flynn
    Christina K. Flynn, PhD

    Chemical engineering; microbiome-derived urinary biomarkers and diagnostics in ASD

    •

    Arizona State University — Biodesign Center for Health Through Microbiomes

    What we've discovered is that 80 to 90% of children with autism have extremely high levels of one or more microbially derived metabolites. Using this test will tell you which young children are at high risk for being diagnosed with autism, and guide treatment in those who have already been diagnosed to help them lead their best lives.

    Source
  • James B. Adams
    James B. Adams, PhD

    Chemical/materials engineering; autism biomedical and microbiome-metabolite research

    •

    Arizona State University

    What’s really striking about the bacteria is that they make metabolites that are basically altered versions of serotonin and dopamine. These are two key neurotransmitters that affect mood, cognition and memory. This could explain many of the symptoms and co-occurring symptoms in children with autism — their social communication, anxiety, depression and attention.

    Source
  • Rosa Krajmalnik-Brown
    Rosa Krajmalnik-Brown, PhD

    Environmental engineering; human gut microbiome and ASD

    •

    Arizona State University

    I am excited about the MDM test, which includes important microbial metabolites, previously hypothesized to be linked with autism. This test can be a great way to assess this important microbial contribution.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Flexible Solutions With FlexVUE
Screening and monitoring
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

What’s New in Infectious Disease? (December 2021)
Screening and monitoring
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

A Pig In a Poke
Screening and monitoring
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Screening and monitoring
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.